Gene test could make painkillers safer for seniors
NCT ID NCT07484867
First seen Mar 22, 2026 · Last updated May 14, 2026 · Updated 10 times
Summary
This study examined how genetic differences in the CYP2D6 enzyme influence pain relief from oxycodone in 100 elderly patients undergoing lung cancer surgery. The goal was to tailor pain management to each patient's genetic profile, reducing side effects and improving pain control. Results may help doctors choose safer, more effective painkillers for older adults.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PAIN are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Henan Provincial People's Hospital
Zhengzhou, Henan, 450000, China
Conditions
Explore the condition pages connected to this study.